Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

Abstract Introduction Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States. Few studies have investigated prescribing patterns among rheumatologists who have initiated secukinumab for the treatment of patie...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Prashanth Sunkureddi, Dominick Latremouille-Viau, Mark K. Meiselbach, Jipan Xie, Peter Hur, Reeti Joshi
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Adis, Springer Healthcare 2019-01-01
Σειρά:	Rheumatology and Therapy
Θέματα:	Biologicals Epidemiology Psoriatic arthritis Spondylarthropathies
Διαθέσιμο Online:	http://link.springer.com/article/10.1007/s40744-018-0137-z
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!